Sodium diethylcarbamodithioate trihydrate

Sodium diethylcarbamodithioate (Ditiocarb sodium) trihydrate is a copper reagent. The reaction with Cu2+ solution resulted in the formation of a complex, which increased the copper displacement precipitation rate. Sodium diethylcarbamodithioate trihydrate can reduce HIV infection and can be used in adjuvant immune research of high-risk breast cancer[1][2][3].

Product Specifications

CAS Number

[20624-25-3]

Product Name Alternative

Ditiocarb sodium trihydrate

UNSPSC

12352200

Hazard Statement

H302, H315, H318

Target

Biochemical Assay Reagents; HIV

Type

Biochemical Assay Reagents

Related Pathways

Anti-infection; Others

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/sodium-diethylcarbamodithioate-trihydrate.html

Purity

98.0

Solubility

DMSO : 200 mg/mL (ultrasonic)

Smiles

CCN(C(S[Na])=S)CC.O.O.O

Molecular Formula

C5H16NNaO3S2

Molecular Weight

225.31

Precautions

H302, H315, H318

References & Citations

[1]Abeer A.El-Saharty, et al. Sodium diethyldithiocarbamate as accelerator of the rate of copper cementation. The Egyptian Journal of Aquatic Research. 2015 Dec, Volume 41 (4) :289-293.|[2]Hersh EM, et al. Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study. JAMA. 1991 Mar 27;265 (12) :1538-44. |[3]Dufour P, et al. Sodium dithiocarb as adjuvant immunotherapy for high risk breast cancer: a randomized study. Biotherapy. 1993;6 (1) :9-12.